Development and validation of a registry-based definition of eosinophilic esophagitis in Denmark by Dellon, Evan S. et al.
BRIEF ARTICLE
Development and validation of a registry-based definition 
of eosinophilic esophagitis in Denmark
Evan S Dellon, Rune Erichsen, Lars Pedersen, Nicholas J Shaheen, John A Baron, Henrik T Sørensen, Mogens Vyberg
World J Gastroenterol  2013 January 28; 19(4): 503-510
ISSN 1007-9327 (print)  ISSN 2219-2840 (online)




503 January 28, 2013|Volume 19|Issue 4|WJG|www.wjgnet.com
Evan S Dellon, Nicholas J Shaheen, Center for Esophageal 
Diseases and Swallowing, and Center for Gastrointestinal Biol-
ogy and Disease, Division of Gastroenterology and Hepatology, 
Department of Medicine, University of North Carolina School of 
Medicine, Chapel Hill, NC 27599-7080, United States
Evan S Dellon, Nicholas J Shaheen, John A Baron, Center 
for Gastrointestinal Biology and Disease, Division of Gastro-
enterology and Hepatology, Department of Medicine, Univer-
sity of North Carolina School of Medicine, Chapel Hill, NC 
27599-7080, United States
Rune Erichsen, Lars Pedersen, Henrik T Sørensen, Depart-
ment of Clinical Epidemiology, Aarhus University Hospital, 
8000 Aarhus, Danmark
Mogens Vyberg, Institute of Pathology, Aalborg Hospital, Aar-
hus University Hospital, 8000 Aarhus, Danmark
Author contributions: All the authors designed the study, inter-
preted the data, and approved the final manuscript draft; Vyberg 
M performed histologic analysis; Dellon ES, Erichsen R and 
Pedersen L performed statistical analysis; Dellon ES drafted the 
paper with critical review from Erichsen R, Pedersen L, Shaheen 
NJ, Baron JA, Sørensen HT and Vyberg M.
Supported by Pilot/feasibility Grant from the UNC Center for 
Gastrointestinal Biology and Disease, NIH P30 DK34987; and 
NIH award K23DK090073 (in part)
Correspondence to: Evan S Dellon, MD, MPH, Center for Eso-
phageal Diseases and Swallowing, Division of Gastroenterol-
ogy and Hepatology, Department of Medicine, University of 
North Carolina School of Medicine, CB#7080, Bioinformatics 
Building, 130 Mason Farm Road, UNC-CH, Chapel Hill, NC 
27599-7080, United States. edellon@med.unc.edu
Telephone: +1-919-9662513     Fax: +1-919-8432508
Received: September 12, 2012  Revised: November 15, 2012
Accepted: November 24, 2012
Published online: January 28, 2013
Abstract
AIM: To develop and validate a case definition of eo-
sinophilic esophagitis (EoE) in the linked Danish health 
registries.
METHODS: For case definition development, we que-
ried the Danish medical registries from 2006-2007 to 
identify candidate cases of EoE in Northern Denmark. 
All International Classification of Diseases-10 (ICD-10) 
and prescription codes were obtained, and archived 
pathology slides were obtained and re-reviewed to de-
termine case status. We used an iterative process to 
select inclusion/exclusion codes, refine the case defini-
tion, and optimize sensitivity and specificity. We then 
re-queried the registries from 2008-2009 to yield a vali-
dation set. The case definition algorithm was applied, 
and sensitivity and specificity were calculated.
RESULTS: Of the 51 and 49 candidate cases identified 
in both the development and validation sets, 21 and 24 
had EoE, respectively. Characteristics of EoE cases in 
the development set [mean age 35 years; 76% male; 
86% dysphagia; 103 eosinophils per high-power field 
(eos/hpf)] were similar to those in the validation set 
(mean age 42 years; 83% male; 67% dysphagia; 77 
eos/hpf). Re-review of archived slides confirmed that 
the pathology coding for esophageal eosinophilia was 
correct in greater than 90% of cases. Two registry-
based case algorithms based on pathology, ICD-10, 
and pharmacy codes were successfully generated in 
the development set, one that was sensitive (90%) and 
one that was specific (97%). When these algorithms 
were applied to the validation set, they remained sensi-
tive (88%) and specific (96%). 
CONCLUSION: Two registry-based definitions, one hi-
ghly sensitive and one highly specific, were developed 
and validated for the linked Danish national health data-
bases, making future population-based studies feasible.
© 2013 Baishideng. All rights reserved.
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Eosinophilic esophagitis (EoE) is a chronic immune-
mediated disorder characterized by symptoms of  esoph-
ageal dysfunction and infiltration of  the esophageal mu-
cosa by eosinophils[1]. While the first case was described 
in 1978[2], a set of  case series in the early 1990s high-
lighted what are now viewed as the classic clinicopatho-
logic features of  EoE[3-5]. Since that time, there has been 
a remarkable increase in the incidence and prevalence 
of  EoE[6-14], EoE has been detected in up to 16% of  
patients undergoing upper endoscopy for dysphagia[15-17], 
and EoE is now the leading cause of  food impaction in 
patients presenting to emergency departments[18-20]. Most 
data regarding the evolving epidemiology of  EoE origi-
nate from tertiary centers[7-13], and there have been few 
population-based studies of  EoE across centers or at a 
national level.
The national population-based medical registries of  
Denmark, which link medical records, diagnostic codes, 
pathology findings, and prescription medications via 
an individual identifier assigned to every person in the 
country[21-24], offer a unique opportunity to systematically 
study the epidemiology of  EoE. However, no validated 
registry-based case definitions of  EoE exist, and this 
limitation hampers any attempt to accurately study EoE 
in Denmark and other countries where national health 
databases are maintained.
The aims of  this study were to characterize candidate 
and definite EoE cases in Northern Denmark detected 
through a search of  the health registries, and to develop 
and validate a registry-based case definition of  EoE in 
the linked Danish clinical, pathology, and pharmacy data-
bases that could be used for future epidemiologic study.
MATERIALS AND METHODS
Denmark health registries
This retrospective study of  the Danish medical registries 
was approved by both the University of  North Carolina 
IRB and the Danish Data Protection Agency (record num-
ber 2010-41-4986). Denmark, with its stable population 
of  approximately 5.5 million people, is well-suited for ep-
idemiological studies[21-24]. The establishment of  the Civil 
Registration System in 1968 allows information about the 
same person to be linked across independent registries by 
using the Civilian Registration Number, a unique identi-
fier assigned to every person in the country[23].
Three of  the comprehensive national medical regis-
tries in Denmark were utilized to generate the necessary 
data for this study. These included: the Danish National 
Registry of  Patients, which houses International Classifi-
cation of  Diseases-10 (ICD-10) codes dating from 1994, 
hospital admission and discharge codes, surgical proce-
dure codes, and outpatient visit codes[25]; the National 
Pathology Registry, which contains Systematized Nomen-
clature of  Medicine (SNOMED) codes for pathologic 
specimens dating from 1997[24]; and the Aarhus University 
Prescription Database, which has outpatient prescription 
data for Northern Denmark using Anatomical Therapeu-
tic Chemical (ATC) classification system codes[26].
For the purposes of  this study we limited our analysis 
to Northern Denmark. This geographic area contains 1.8 
million inhabitants, approximately 1/3 of  the Danish pop-
ulation, and allowed ready access to the required pathol-
ogy specimens for case verification, as described below.
Case definition development
This study utilized two independent sets of  patients, one 
set in which to develop the case definition and one set in 
which to validate it.
For case definition development, we queried the Na-
tional Pathology Registry from 2006-2007 in Northern 
Denmark to identify candidate cases of  EoE. These were 
patients with esophageal eosinophilia as defined by the 
combination of  SNOMED codes for esophageal biop-
sies (T62xxx) and tissue eosinophilia (M47150). These 
codes were assigned by the clinical pathologist at the time 
of  specimen examination and interpretation. Next, all 
ICD-10 diagnostic and ATC prescription codes for these 
patients were obtained from the National Registry of  Pa-
tients and the Aarhus University Prescription Database, 
respectively. Finally, the original archived pathology slides 
were obtained and, using a previously validated proto-
col[27], were re-reviewed by the study pathologist (Vyberg 
M) to determine the maximum eosinophil count [eosino-
phils per high-power field (eos/hpf); hpf  = 0.24 mm2].
From this pool of  subjects with esophageal eosino-
philia, we identified the subset of  patients with a con-
firmed diagnosis of  EoE as per consensus diagnostic gui-
delines[1,28]. Specifically, these patients had symptoms of  
esophageal dysfunction, a maximum eosinophil count ≥ 
15 eos/hpf  on pathology re-review, and no other com-
peting causes of  esophageal eosinophilia identified. While 
the current consensus guidelines allow reflux and EoE to 
overlap[1], we attempted to minimize this overlap by en-
suring that there was not a mixed inflammatory infiltrate 
on the re-reviewed esophageal biopsies and by assessing 
use of  anti-acid mediations in the months preceding the 
diagnostic endoscopy (see below). These subjects with 
confirmed EoE comprised the reference standard for the 
case definition development set.
We used an iterative process to develop a case defini-
tion of  EoE based on previously described methodol-
ogy for gastrointestinal disorders used in the Danish and 
other administrative databases[29-31]. First, we empirically 
selected a combination of  SNOMED, ICD-10 and ATC 
codes that were potentially pertinent to the diagnosis of  
EoE and could exclude disorders on the differential diag-
nosis for esophageal eosinophilia as well as patients with 
non-EoE conditions with similar symptom profiles. Next, 
the National Pathology Registry, National Registry of  Pa-
505 January 28, 2013|Volume 19|Issue 4|WJG|www.wjgnet.com
tients, and Aarhus University Prescription Database were 
queried using this combination of  codes to provide a 
set of  possible EoE patients. Then, using the confirmed 
EoE cases previously identified as the reference standard, 
the sensitivity and specificity of  this initial search strategy 
were determined within the population of  patients with 
esophageal eosinophilia. Sensitivity was calculated by di-
viding the number of  true positive EoE cases identified 
using the case definition by the total number of  reference 
standard EoE cases. Specificity was calculated by dividing 
the number of  true negative subjects identified using the 
case definition by the total number of  subjects without 
EoE. By examining the coding and patient characteristics 
of  those classified as false positive and false negative, the 
administration case definition was further refined, the 
databases were re-queried with the updated definition, 
and new operating characteristics were calculated. This 
process continued until sensitivity and specificity were 
optimized.
Case definition validation
Using the same methodology as described for case defi-
nition development, the case definition was validated in 
an independent population in Northern Denmark from 
2008-2009. In brief, candidate cases of  EoE were identi-
fied based on SNOMED codes, and a reference standard 
set of  patients with confirmed EoE in the new time 
frame was created after re-review of  original pathology 
slides and all coding data. The administrative case defini-
tion algorithm was then applied to the National Pathol-
ogy Registry, National Registry of  Patients, and Aarhus 
University Prescription Database, the set of  possible EoE 
cases was generated, and sensitivity and specificity were 
calculated using the confirmed EoE cases as the reference 
standard.
RESULTS
Characteristics of the development set
There were 51 patients with esophageal eosinophilia iden-
tified in Northern Denmark from 2006-2007, and 21 (41%) 
had a confirmed diagnosis of  EoE (Table 1). This group 
comprised the reference standard for the development set. 
Patients with esophageal eosinophilia had a mean age of  
42 years, 75% were male, and almost half  had dysphagia. 
While the EoE patients had a similar proportion of  males 
(76%), they were somewhat younger (35 years), and 86% 
had dysphagia. The maximum eosinophil count was 71 
eos/hpf  in all patients with esophageal eosinophilia, and 
103 eos/hpf  in patients with confirmed EoE. The pathol-
ogy re-review of  slides confirmed that the SNOMED 
coding for esophageal eosinophilia was correct in the vast 
majority of  cases, with 90% meeting criteria for histologic 
EoE (≥ 15 eos/hpf) (Figure 1).
Characteristics of the validation set
There were 49 patients with esophageal eosinophilia iden-
tified in Northern Denmark from 2008-2009, and 24 (49%) 
had a confirmed diagnosis of  EoE (Table 1). This group 
comprised the reference standard for the validation set. 
Patients with esophageal eosinophilia had a mean age of  
48 years, 73% were male, and 39% had dysphagia. While 
the EoE patients had a similar proportion of  males (83%), 
they were also somewhat younger (42 years) and 67% had 
dysphagia. The maximum eosinophil count was 68 eos/
hpf  in all patients with esophageal eosinophilia, and 77 
eos/hpf  in patients with confirmed EoE. Overall, the clin-
ical characteristics of  the EoE cases in the development 
and validation sets were similar, and pathology re-review in 
the validation set also confirmed correct SNOMED cod-
ing in 90% of  cases (Figure 1).
EoE case definition algorithms and operating characteristics
The iterative methodology for case definition develop-
ment and validation yielded two registry-based case diag-
nostic algorithms, one that was highly sensitive and one 
that was highly specific. The highly sensitive case defini-
tion maximized the number of  cases of  EoE that were 
identified in the database search, while the highly specific 
definition accepted a lower sensitivity (i.e., not identifying 
all EoE cases) in exchange for ensuring that all cases were 
true EoE cases (i.e., minimizing false positives).
The final case definition algorithms are presented in 
Table 2. The “sensitive” algorithm has three steps. The 
Table 1  Characteristics of the case definition development set (2006-2007) and validation set (2008-2009)  n  (%)
Development set (2006-2007) Validation set (2007-2008)
Overall 
(n  = 51)
EoE 
cases 
(n  = 21)
Sensitive 
definition 
(n  = 31)
Specific 
definition 
(n  = 9)
Overall 
(n  = 49)
EoE 
cases 
(n  = 24)
Sensitive 
definition 
(n  = 26)
Specific 
definition 
(n  = 6)
Age, yr (mean ± SD) 42 ± 19   35 ± 16 40 ± 18 38 ± 19 48 ± 21 42 ± 15 49 ± 19 49 ± 19
Male 38 (75) 16 (76) 22 (71)    7 (78) 36 (73) 20 (83) 21 (81) 4 (67)
Dysphagia 24 (47) 18 (86) 28 (90)   8 (89) 19 (39) 16 (67) 18 (69) 3 (50)
Esophageal foreign body 15 (29) 11 (52) 14 (45)   3 (33) 8 (16) 2 (8) 4 (15) 1 (17)
Rhinitis/sinusitis   5 (10)   2 (10) 2 (6)   1 (11) 0 (0) 0 (0) 0 (0) 0 (0)
Asthma 3 (6) 1 (5) 1 (3) 0 (0) 2 (4) 2 (8) 2 (8) 1 (17)
PPI use 38 (75) 17 (81) 21 (68)     9 (100) 33 (67) 12 (50) 21 (81) 6 (100)
Maximum eosinophil count, 
eos/hpf (mean ± SD)
71 ± 53 103 ± 54 84 ± 58 93 ± 83 68 ± 71 77 ± 62 60 ± 35 43 ± 31
EoE: Eosinophilic esophagitis; PPI: Proton-pump inhibitor; eos/hpf: Eosinophils per high-power field.
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first uses SNOMED codes to include all patients with 
esophageal eosinophilia. The second excludes patients 
if  they have any one of  eleven ICD-10 codes that could 
cause non-EoE related esophageal eosinophilia or esoph-
ageal injury that could mimic EoE clinically. The third 
requires patients to have at least one of  13 ICD-10 codes 
for symptoms of  esophageal dysfunction. The “specific” 
algorithm has an additional step to exclude false positives 
which requires a documented proton-pump inhibitor (PPI) 
or histamine-2 receptor antagonist prescription within 2 
mo of  the esophageal biopsy date.
When these algorithms were applied to the develop-
ment set, the clinical characteristics of  the cases identi-
fied for both the sensitive definition (n = 31; mean age 
40 years; 71% male; 90% dysphagia; 84 eos/hpf) and the 
specific definition (n = 8; mean age 38 years; 78% male; 
89% dysphagia; 93 eos/hpf) were similar to those for the 
reference standard EoE cases (Table 1).
Table 2  Case definition algorithm
For both the sensitive and the specific case definitions:
   (1) Include all patients with systematized nomenclature of medicine M47150 (finding of tissue eosinophil) and T62xxx (esophageal biopsy)
   (2) Exclude patients if they have one of the following International Classification of Diseases-10 codes occurring at any time:
      B20.x - human immunodeficiency virus
      C15.x - malignant neoplasm of esophagus
      C16.0 - malignant neoplasm of cardia
      C92.x - myeloid leukemia
      C94.x - other leukemias of specialized cell type
      C96.x - other and unspecified lymph/heme malignancies
      K22.0 - achalasia
      K50.x - Crohn’s disease
      K52.8 - eosinophilic gastritis/duodenitis 
      T28.1 - burn of esophagus
      T28.6 - corrosion of esophagus
   (3) Include patients if one of the following International Classification of Diseases-10 codes is present at or before the date of the procedure:
      K22.2 - esophageal obstruction
      K30.9 - dyspepsia
      P92.x - feeding problems of the newborn
      R07.x - pain in throat and chest
      R10.x - abdominal pain
      R11.x - nausea/vomiting
      R12.x - heartburn
      R13.x - dysphagia
      T18.0 - foreign body in mouth
      T18.1 - foreign body in esophagus
      T18.2 - foreign body in stomach
      T18.9 - foreign body in genitourinary tract unspecified
      T98.0 - sequelae of foreign body entering through a natural orifice
Additional requirement for the specific case definition:
   (4) Include patients if there is a proton-pump inhibitor prescription (A02BCxx) or H2RA prescription (A02BAxx) within 2 mo of esophageal biopsy date,
   up to and including 2 d prior to the esophagogastroduodenoscopy
< 10           10-14           15-30           31-45          46-60           61-75         76-100         101-200         > 200
Development
Validation

















Figure 1  Distribution of levels of esophageal eosinophilia in the development and validation sets of candidate cases of eosinophilic esophagitis identi-
fied in the Denmark medical registries. Ranges of esophageal eosinophilia [in eosinophils per high-power field (eos/hpf)] determined after pathology re-review of 
archived slides are on the x axis. The typical histologic threshold for considering a diagnosis of eosinophilic esophagitis in the appropriate clinical context of 15 eos/hpf 
is indicated with a dotted line.
Dellon ES et al . Registry-based definition of EoE
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When these algorithms were applied to the valida-
tion set, the clinical features for the sensitive definition 
(n = 26; mean age 49 years; 81% male; 69% dysphagia; 
60 eos/hpf) and specific definition (n = 6; mean age 49 
years; 67% male; 50% dysphagia; 43 eos/hpf) were also 
similar to those for the reference standard for EoE cases 
(Table 1).
In the development set, the “sensitive” algorithm had 
a sensitivity and specificity of  90% and 60%, and the 
“specific” algorithm had values of  38% and 97%, respec-
tively (Table 3). When these algorithms were applied to 
the validation set, the operating characteristics were es-
sentially unchanged, with a sensitivity and specificity of  
88% and 80%, for the “sensitive” algorithm, and 21% 
and 96% for the “specific” algorithms.
DISCUSSION
The epidemiology of  EoE has been rapidly evolving 
over the past two decades, with a marked increase in 
incidence and prevalence. The study of  EoE in large 
national or administrative databases, however, has been 
hampered by the lack of  a validated case definition of  
EoE and the difficulty of  developing such a definition 
due to the clinicopathologic nature of  the disorder. This 
study takes advantage of  the fact that the health regis-
tries in Denmark can link pathologic data to diagnostic 
and prescription coding data, thus providing all of  the 
needed components to identify cases of  EoE.
There are two main results for this study. The first is 
that the confirmed EoE cases identified in Denmark via 
the health registries had similar features to those reported 
both in Denmark as well as elsewhere in the world[1,7-17,32-35]. 
The second is that two registry-based case definitions, 
one highly sensitive and one highly specific, were suc-
cessfully developed and validated for use in the Danish 
national health databases. This is the first study to do so, 
and this result makes future large-scale population-based 
studies feasible in that country. This is important because 
the majority of  investigations studying the epidemiology 
of  EoE are either from selected counties within a coun-
try or region, from single centers but are not population-
based, or from larger databases that have limitations.
For example, in the two counties studied in northern 
Sweden during the Kalixanda study, Ronkainen et al[36] 
found that 11 of  1000 (1.1%) subjects had prevalent 
esophageal eosinophilia ≥ 15 eos/hpf. While this is the 
only published study with a true population-based sam-
pling strategy, these individuals would not necessarily 
meet current EoE diagnostic guidelines because not all 
were symptomatic and competing causes of  esophageal 
eosinophilia were not excluded[1,28]. In Olten County, Swit-
zerland, a well-defined geographic region with a stable 
population and practitioners who are expert in EoE diag-
nosis, Hruz et al[14] have recently updated their estimates 
of  the incidence (7/100 000) and prevalence (43/100 000) 
of  EoE[12]. Prasad et al[9] reported similar estimates from 
Olmstead County, Minnesota (incidence 9/100 000; prev-
alence 55/100 000) in patients identified retrospectively, 
and Spergel et al[37] derived a similar prevalence estimate 
(52/100 000) from physician surveys. In all of  these stud-
ies, however, the included patients and providers were 
not sampled in population-based frames.  Additional 
retrospective single center studies, while providing im-
portant data, are subject to similar limitations[7,8,10,11,13,38,39]. 
Three prospective studies examining the prevalence of  
EoE in patients undergoing upper endoscopy for any 
symptom[17], or for dysphagia provide equally important 
data[15,16], but are also from single centers and enrolled 
patients who were actively undergoing evaluation and so 
cannot necessarily be generalized to an entire popula-
tion. In a series of  studies that utilized a large pathology 
database in the United States, the national distribution of  
esophageal eosinophilia and EoE has been confirmed, 
but the data are also not population based[40-42]. Most 
recently, abstract data from the national health system in 
the Netherlands has been presented showing a rapid rise 
in the incidence of  esophageal eosinophilia, but this study 
did not employ a validated case definition of  EoE[43]. 
The current study attempts to address the challenges en-
countered in the definition of  EoE when using county- 
or national-level database or registry data, and to set the 
stage for conducting true population-level EoE research.
There are both limitations and strengths of  this study 
that should be acknowledged. The first issue is whether 
there could be misclassification of  cases of  EoE in the 
reference standard groups. This appears to be unlikely 
given that histology, symptom coding, and prescription 
data were used to apply EoE consensus diagnostic guide-
lines to the study population. Nevertheless, because this 
is a retrospective analysis, we cannot completely exclude 
the possibility of  overlap between gastroesophageal re-
flux disease and EoE, and are unable to fully address the 
issue of  PPI-responsive esophageal eosinophilia (PPI-
REE). It is interesting to observe, however that only 41% 
and 49% of  subjects with esophageal eosinophilia were 
confirmed to have EoE in the development and valida-
tion sets, respectively, suggesting that half  or more of  
subjects with esophageal eosinophilia do not have EoE. 
The proportion of  subjects with esophageal eosinophilia 
who did not have EoE in our study is similar to the re-
ported proportion of  subjects with esophageal eosino-
philia who have PPI-REE, ranging in various studies 
from approximately 30%-75%[44-48]. The poor specificity 









Sensitivity 90 (90) 38 (38) 88 (88) 21 (21)
Specificity 60 (60) 97 (97) 80 (80) 96 (96)
1Sensitivity: Number of true positive eosinophilic esophagitis (EoE) cases 
identified by the case definition divided by the total number of reference 
standard EoE cases; Specificity: Number of true negative subjects identified 
by the case definition divided by the total number of subjects without EoE.
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of  the presence of  esophageal eosinophilia for the diag-
nosis of  EoE, coupled with the high proportion of  sub-
jects with esophageal eosinophilia who have PPI-REE, 
emphasize that esophageal eosinophilia alone is not ad-
equate for case-finding of  EoE in pathology databases, 
and cannot be used in isolation to diagnose EoE[1,28,49,50]. 
A related point is that while it is a strength of  this study 
to have obtained and re-reviewed the original pathology 
slides, it is important to acknowledge that the biopsies 
were originally taken for clinical purposes at the discre-
tion of  individual endoscopists, and the location and 
number of  biopsies could vary.
It is a strength of  the study that two case definitions, 
one sensitive and one specific, were developed. In in-
stances where overlap or misclassification may be a con-
cern, the “specific” algorithm could be used to ensure the 
most homogenous EoE population is generated. The two 
case definitions also allow for bounding and perform-
ing sensitivity analyses around epidemiologic estimates. 
Moreover, the use of  the linked Denmark databases is 
another strength of  this study, as there are relatively few 
data sources that are as rich and contain patient-level 
pathology information linked to administrative coding. 
This is illustrated by our ability to obtain and re-review 
the original glass pathology slides in order to validate the 
SNOMED codes for esophageal eosinophilia.
The case definitions developed in this study are de-
rived from the Denmark databases and it is unknown 
whether these would be valid in other settings.  How-
ever, the methodology presented here could be readily 
replicated in different databases to validate EoE case 
definitions, and our proposed algorithm could be used 
as a starting point in an iterative process to develop case 
definitions in other databases.
In conclusion, this study of  the linked Danish nation-
al health registries successfully identified and confirmed 
cases of  EoE in Denmark. Two administrative registry-
based case definitions, one highly sensitive to maximize 
the number of  cases of  EoE identified, and one highly 
specific to minimize the number of  false positive EoE 
cases included, were developed and validated. The oper-
ating characteristics of  the case algorithms are sufficient 
to support future population-based studies of  the epide-
miology of  EoE in Denmark, and may serve as a tem-
plate for developing similar definitions in other databases.
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